6.3 Laboratory Quality Management & SOPs
Key Takeaways
- Laboratory quality management includes SOPs, inventory control, customer satisfaction processes, training, and complete documentation—not only running a syringe check.
- QC logs are linked to report release authority: patient results should not be released for a channel that is out of control or past required verification.
- Serial testing of the same patient over time is both a clinical tool and a quality signal when unexpected shifts appear without clinical change.
- NBRC DCO III.A.17–19 covers serial pulmonary function testing (17), clinical history and demographics (18), and laboratory quality management (19).
From Individual Checks to a Managed Laboratory
Domains I and II teach you to calibrate instruments and perform tests. Domain III Data Management asks whether the laboratory can turn those actions into defensible, consistent information. Subtasks III.A.17–19 cover serial pulmonary function testing (17), clinical history and demographics (18), and laboratory quality management (19). An RPFT is expected to operate inside a quality system—not invent ad-hoc rules when the schedule is busy.
Quality management is broader than “did QC pass this morning?” It includes written procedures, supply integrity, staff competency, complaint handling, document control, and the authority pathway that decides when a report may leave the lab.
Standard Operating Procedures (SOPs)
SOPs are controlled documents that define how the lab performs work the same way every day.
| SOP domain | Examples of content |
|---|---|
| Instrument operation | Warm-up, calibration, mechanical QC frequency, acceptance limits |
| Procedures | Spirometry, DLCO, lung volumes, ABG sampling/analysis per ATS/ERS and manufacturer |
| Infection control | Filter changes, disinfection, airborne precautions |
| QC & PT | Bio-control schedules, control rules, PT handling, out-of-control algorithms |
| Reporting | Who may release results, critical value notification, amended reports |
| Safety | Emergency equipment, electrical/gas safety, spill response |
Document control principles (exam-level):
- Only the current approved version is used at the bench.
- Obsolete SOPs are removed or clearly archived.
- Changes are reviewed/approved; staff are trained on revisions.
- “Tribal knowledge” (verbal only) is a risk finding—if it matters, it belongs in the SOP.
When an exam stem shows two technologists doing DLCO breath-hold timing differently, the quality answer is not “both are fine if the numbers look pretty.” Align to the SOP and standards; retrain; document.
Inventory Control
PFT and blood gas quality collapse when consumables are wrong, expired, or mixed across instruments.
| Inventory item | Quality risk if mismanaged |
|---|---|
| Calibration syringes / ILA | Damaged standards invalidate mechanical QC |
| Calibration and test gases | Wrong assay values → wrong DLCO/span; empty tanks mid-clinic |
| Blood gas reagents/cartridges/controls | Expired packs → failed QC or biased patient results |
| Filters, mouthpieces, nose clips | Stockouts force unsafe reuse or canceled testing |
| Desiccants / Nafion / absorbers | Exhausted conditioners bias gas analyzers |
| PT kits | Missed deadlines or improper storage void the event |
Inventory control actions: lot numbers and expiration dating, first-expire-first-out, segregated storage for quarantine/expired goods, cylinder assay certificates on file, and par levels so critical QC materials never run out on a testing day. Changing a gas lot or reagent lot is a planned process change—verify calibration/QC after the change per SOP.
Customer Satisfaction and Service Quality
“Customer” in a PFT lab includes patients, ordering providers, and receiving clinicians. Quality management tracks more than FEV1 precision:
- Appointment access and wait times
- Clear instructions (withhold bronchodilators when ordered, smoking abstinence for DLCO, etc.)
- Respectful coaching without coaching fabrication of numbers
- Timely report turnaround
- Responsive handling of complaints or amended-report requests
- Infection-control confidence
A lab that produces accurate numbers but routinely loses orders, mislabels patients, or releases reports to the wrong chart still fails quality management. RPFT items may frame this as process failure rather than electrode chemistry.
Documentation — If It Was Not Recorded, It Was Not Done
Minimum documentation culture for high-cut RPFT thinking:
| Record type | Why it exists |
|---|---|
| QC logs (mechanical, material, biological) | Prove instruments were verified before patients |
| Maintenance / service logs | Link repairs to later performance shifts |
| PT results and corrective actions | External performance history |
| Training / competency records | Show who is authorized to perform tests |
| Incident / nonconformance reports | Capture failures and fixes |
| Report release / amendment trail | Who released what, when, and under what QC status |
Electronic systems help, but only if timestamps, user IDs, and out-of-control flags are real. Backdating QC after a bad patient result is a critical integrity failure.
Linking QC Logs to Report Release Authority
This is a high-yield decision rule:
No valid QC → no patient report release for the affected measurement.
Practical implications:
- Channel-level status: PO2 QC fail may allow pH/PCO2 release if independent and SOP allows; DLCO fail does not block a separately verified spirometer if systems are independent.
- Time window: If SOP requires QC every 8 hours or after N patients, expired QC status blocks further release until QC is repeated.
- Authority: Defined roles (technologist, senior tech, medical director) decide return-to-service and whether results obtained during an ambiguous period are voided or repeated.
- Amended reports: If a problem is found after release (e.g., wrong gas assay discovered), follow SOP for correction, clinician notification, and documentation—do not silently edit.
Exam trap: “The patient drove two hours; we should release the DLCO even though bio-control and span failed.” Correct action is do not release invalid data; reschedule or use a verified backup system.
Serial Testing QC — Same Patient Over Time as a Quality Signal
III.A.17-style serial PFT data is clinically essential (treatment response, transplant follow-up, drug toxicity surveillance). It is also a quality sensor:
| Serial observation | Possible quality issue | Clinical alternative |
|---|---|---|
| Sudden 400 mL FEV1 drop with perfect prior reproducibility, no symptoms, new filter brand today | Mouthpiece/filter leak, calibration, software update | True obstruction progression |
| DLCO falls 5 units after CO tank lot change, spirometry stable | Gas concentration/analyzer problem | True gas-exchange decline |
| All afternoon patients show lower volumes after morning pass | Progressive pneumotach moisture/zero drift | Unlikely that every patient worsened identically |
| One patient improved dramatically only when a different technologist tested | Coaching or effort inconsistency | Real clinical improvement |
III.A.18 clinical history and demographics matter here: smoking status, hemoglobin for DLCO, recent bronchodilator use, altitude/transfer, infection, and surgical history prevent mislabeling a physiologic change as instrument error—and the reverse. Quality management means integrating QC status, serial trends, and clinical context before releasing an interpretation-ready dataset.
Putting III.A.17–19 Together
| DCO element | RPFT management behavior |
|---|---|
| III.A.17 Serial pulmonary function testing | Compare current vs prior studies; flag implausible shifts for technical review |
| III.A.18 Clinical history and demographics | Use age, race, sex, smoking history, medication, and clinical indication so technical and clinical decisions are informed |
| III.A.19 Laboratory quality management | Maintain SOPs, inventory control, customer satisfaction processes, training, QC/PT programs, documentation |
A complete quality system therefore has three closed loops:
- Pre-analytic / instrument loop — mechanical QC, calibrations, inventory, warm-up (Domain I).
- Analytic loop — procedure standards, acceptability, biological QC, PT (Domains I–II).
- Post-analytic / management loop — documentation, release authority, serial review, clinical context, customer feedback (Domain III).
When any loop breaks, the RPFT’s job is to stop the defective product (invalid report), fix the process, and only then restart testing. That discipline is what Domain I.C QC devices and Domain III quality management items are written to protect—and what separates a high-cut credential from simply collecting waveforms.
Chapter Close
Chapter 6 tied mechanical devices (6.1), biological controls and proficiency testing (6.2), and laboratory quality management (6.3) into one QC system. Downstream chapters assume these gates work: patient preparation, spirometry, volumes, DLCO, and blood gas procedures only produce usable clinical data when quality control and quality management are already green.
Which set best represents laboratory quality management beyond a single morning syringe check?
DLCO analyzer span and the staff bio-control both fail after a gas cylinder change. The patient has already completed maneuvers. What is the correct report-release decision?
How can serial PFT testing of the same patient function as a quality signal?
Which example best matches DCO III.A.18-style use of clinical history and demographics in laboratory quality decisions?